Accelerating stem cell proliferation by down-regulation of cell cycle regulator p21

Plastic and Reconstructive Surgery

Volumn 123, Issue SUPPL.2S, 2009, Pages

  Plasilova, Magdalena ^a   Schonmyer, Bjorn ^a   Fernandez, John ^a   Clavin, Nicholas ^a   Soares, Mark ^a   Mehrara, Babak J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN P21; SMALL INTERFERING RNA; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROTEIN KINASE INHIBITOR;

ACCELERATION; ANIMAL CELL; BONE; CELL CULTURE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL KINETICS; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RNA INTERFERENCE; STEM CELL; TISSUE ENGINEERING; WILD TYPE; ANIMAL; ARTICLE; DRUG EFFECT;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; MESENCHYMAL STEM CELLS; MICE; PROTEIN KINASE INHIBITORS;

EID: 61749088477     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e318191c82b     Document Type: Conference Paper

References (22)

1. Mauney J, Volloch V, Kaplan D. Role of adult mesenchymal stem cells in bone tissue engineering applications: Current status and future prospects. Tissue Eng. 2005;11:787-802.
2. Kippin TE, Martens DJ, van der Kooy D. p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity. Genes Dev. 2005;19:756-767.
3. Cheng T, Rodrigues N, Shen H, et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000; 287:1804-1808.
4. Bokoch GM. Biology of the p21-activated kinases. Annu Rev Biochem. 2003;72:743-781.
5. Ju Z, Choudhury AR, Rudolph KL. A dual role of p21 in stem cell aging. Ann N Y Acad Sci. 2007;1100:333-344.
6. Sherr C, Roberts J. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 2006;13:1501-1512.
7. Waga S, Hannon G, Beach D, et al. The p21 inhibitor of cyclin dependent kinases controls DNA replication by interacting with PCNA. Nature 1994;369:574-578.
8. el-Deiry W, Tokino T, Velculescu V, et al. WAF1, a potential mediator of p53 tumour suppression. Cell 1993;75:817-825.
9. Matthews C, Gorenne I, Scott S, et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: Effects of telomerase and oxidative stress. Circ Res. 2006;99:156-164.
10. Welle S, Brooks AI, Delehanty JM, et al. Skeletal muscle gene expression profiles in 20-29 year old and 65-71 year old women. Exp Gerontol. 2004;39:369-377.
11. Ding G, Franki N, Kapasi AA, et al. Tubular cell senescence and expression of TGF-beta1 and p21(WAF1/CIP1) in tu-bulointerstitial fibrosis of aging rats. Exp Mol Pathol. 2001; 70:43-53.
12. Alcorta DA, Xiong Y, Phelps D, et al. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA. 1996;93:13742-13747.
13. Nishimura EK, Granter SR, Fisher DE. Mechanisms of hair graying: Incomplete melanocyte stem cell maintenance in the niche. Science 2005;307:720-724.
14. Bellosta P, Masramon L, Mansukhani A, et al. p21(WAF1/ CIP1) acts as a brake in osteoblast differentiation. J Bone Miner Res. 2003;18:818-826.
15. Funato N, Ohtani K, Ohyama K, et al. Common regulation of growth arrest and differentiation of osteoblasts by helix-loop-helix factors. Mol Cell Biol. 2001;21:7416-7428.
16. Westendorf J, Zaidi K, Cascino J, et al. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21CIP1/WAF1 promoter. Mol Cell Biol. 2002;22:7982-7992.
17. Naaz A, Holsberger DR, Iwamoto GA, et al. Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. FASEB J. 2004;18:1925-1927.
18. Morrison R, Farmer S. Role of PPAR gamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c), and p21(Waf1/Cip1), during adipogenesis. J Biol Chem. 1999;174:17088-17097.
19. Kavurma M, Khachigian LJ. Vascular smooth muscle cell-specific regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1) transcription by Sp1 is mediated via distinct cis-acting positive and negative regulatory elements in the proximal p21(WAF1/Cip1) promoter. J Cell Biochem. 2004;93:904-916.
20. Martin-Caballero J, Flores J, Garcia-Palencia P, et al. Tumor susceptibility of p21Waf1/Cip1-deficient mice. Cancer Res. 2001;61:6234-6238.
21. Gartel A, Tyner A. The role of the cyclin-dependent ki-nase inhibitor p21 in apoptosis. Mol Cancer Ther. 2002;1: 639-649.
22. De la Cueva E, Garcia-Cao I, Herranz M, et al. Tumorigenic activity of p21(Waf1/Cip1) in thymic lymphoma. Oncogene 2006;25:4128-4132.